Human PlGF Quantikine PharmPak (50 Plates)

• Supplier: R&D Systems
• Catalog: PDPG00
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (100 µL), Serum (100 µL), EDTA Plasma (100 µL), Heparin Plasma (100 µL), Citrate Plasma (100 µL), Urine (100 µL)
• Sensitivity: 7 pg/mL
• Range: 15.6 - 1,000 pg/mL (Serum, Heparin Plasma, Cell Culture Supernates, Citrate Plasma, EDTA Plasma, Urine)
• Format: 96-well strip plate
• Description: The Quantikine Human PlGF Immunoassay is a 3.5 or 4.5 hour solid phase ELISA designed to measure human PlGF in cell culture supernates, serum, plasma, and urine
• Gene: PGF

Product References

Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell - Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell

Chaturvedi P, Gilkes DM, Wong CC, Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semenza GL. J Clin Invest. 2013 Jan;123(1):189-205.

Integrating multiple 'omics' analyses identifies serological protein biomarkers - Integrating multiple 'omics' analyses identifies serological protein biomarkers

Liu LY, Yang T, Ji J, Wen Q, Morgan AA, Jin B, Chen G, Lyell DJ, Stevenson DK, Ling XB, Butte AJ. BMC Med. 2013 Nov 6;11:236.

Biomarkers for antitumor activity of bevacizumab in gastric cancer models. - Biomarkers for antitumor activity of bevacizumab in gastric cancer models.

Yamashita-Kashima Y, Fujimoto-Ouchi K, Yorozu K, Kurasawa M, Yanagisawa M, Yasuno H, Mori K. BMC Cancer. 2012 Jan 25;12:37.

Cytokine and angiogenic factors associated with efficacy and toxicity of - Cytokine and angiogenic factors associated with efficacy and toxicity of

Sleijfer S, Gorlia T, Lamers C, Burger H, Blay JY, Le Cesne A, Scurr M, Collin F, Pandite L, Marreaud S, Hohenberger P. Br J Cancer. 2012 Aug 7;107(4):639-45.

Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line - Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line

Loupakis F, Cremolini C, Fioravanti A, Orlandi P, Salvatore L, Masi G, Di Desidero T, Canu B, Schirripa M, Frumento P, Di Paolo A, Danesi R, Falcone A, Bocci G. Br J Cancer. 2011 Apr 12;104(8):1262-9.

Expression and prognostic value of circulating angiogenic cytokines in pancreatic - Expression and prognostic value of circulating angiogenic cytokines in pancreatic

Rahbari NN, Schmidt T, Falk CS, Hinz U, Herber M, Bork U, Buchler MW, Weitz J, Koch M. BMC Cancer. 2011 Jul 5;11:286.

Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy - Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy

de Groot JF, Piao Y, Tran H, Gilbert M, Wu HK, Liu J, Bekele BN, Cloughesy T, Mehta M, Robins HI, Lassman A, DeAngelis L, Camphausen K, Chen A, Yung WK, Prados M, Wen PY, Heymach JV. Clin Cancer Res. 2011 Jul 15;17(14):4872-81.

Phase I and pharmacokinetic study of sunitinib in pediatric patients with - Phase I and pharmacokinetic study of sunitinib in pediatric patients with

Dubois SG, Shusterman S, Ingle AM, Ahern CH, Reid JM, Wu B, Baruchel S, Glade-Bender J, Ivy P, Grier HE, Adamson PC, Blaney SM. Clin Cancer Res. 2011 Aug 1;17(15):5113-22.

Placenta growth factor in sickle cell disease: association with hemolysis and - Placenta growth factor in sickle cell disease: association with hemolysis and

Brittain JE, Hulkower B, Jones SK, Strayhorn D, De Castro L, Telen MJ, Orringer EP, Hinderliter A, Ataga KI. Blood. 2010 Mar 11;115(10):2014-20.

Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in - Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in

Ha CT, Wu JA, Irmak S, Lisboa FA, Dizon AM, Warren JW, Ergun S, Dveksler GS. Biol Reprod. 2010 Jul;83(1):27-35.